All In Biotech

Drug Trial Radar · NCT06907173

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 770 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

770

Planned (sponsor's estimate)

Start

Mar 6, 2026

Primary completion

Jun 2029

Study completion Dec 2029

Sponsor

Lead sponsor
University of VirginiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Michigan; Medical University of South Carolina; Massachusetts General Hospital; Children's National Research Institute
First posted
Apr 2, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.

Conditions

  • Status Epilepticus

Interventions

  • Levetiracetam (LEV) (60 mg/Kg) + 1 mg/kg Ketamine (KET)Drug

    The study drug will be produced at the central pharmacy, a GMP facility at the University of California, Davis. Diluted formulations are expected to remain stable for months when stored at room temperature. Expiration dates for study drugs will be determined and adjusted based on ongoing stability testing performed on study drugs prepared at the GMP facility for the study. All three formulations will be transparent solutions. None of the formulations are reported to consistently cause adverse effects at the infusion site. The method of drug administration, including volume and rate of infusion, is identical for all three drugs. These factors ensure that drug administration will be blinded.

  • Levetiracetam (LEV) (60 mg/Kg) + 3 mg/kg Ketamine (KET)Drug

    The study drug will be produced at the central pharmacy, a GMP facility at the University of California, Davis. Diluted formulations are expected to remain stable for months when stored at room temperature. Expiration dates for study drugs will be determined and adjusted based on ongoing stability testing performed on study drugs prepared at the GMP facility for the study. All three formulations will be transparent solutions. None of the formulations are reported to consistently cause adverse effects at the infusion site. The method of drug administration, including volume and rate of infusion, is identical for all three drugs. These factors ensure that drug administration will be blinded.

  • Levetiracetam (LEV) (60 mg/Kg)Drug

    The study drug will be produced at the central pharmacy, a GMP facility at the University of California, Davis. Diluted formulations are expected to remain stable for months when stored at room temperature. Expiration dates for study drugs will be determined and adjusted based on ongoing stability testing performed on study drugs prepared at the GMP facility for the study. All three formulations will be transparent solutions. None of the formulations are reported to consistently cause adverse effects at the infusion site. The method of drug administration, including volume and rate of infusion, is identical for all three drugs. These factors ensure that drug administration will be blinded.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Termination of SETime frame: From 15 minutes after starting the study drug infusion, sustained for 60 minutes without using additional anti-seizure medication.

Locations

63 sites in 1 country. Site status is shown where the registry gives one.

  • UAB Hospital

    Birmingham, Alabama · Not yet recruiting

  • Banner University Medical Center - Tucson Campus

    Tucson, Arizona · Recruiting

  • UC San Diego Health La Jolla

    La Jolla, California · Not yet recruiting

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California · Not yet recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Not yet recruiting

  • Stanford University Medical Center

    Palo Alto, California · Recruiting

  • UC Davis Medical Center

    Sacramento, California · Recruiting

  • UC San Diego Health Hillcrest Hospital

    San Diego, California · Not yet recruiting

  • Rady Children's Hospital

    San Diego, California · Not yet recruiting

  • San Francisco General Hospital

    San Francisco, California · Recruiting

  • UCSF Medical Center

    San Francisco, California · Recruiting

  • Harbor-UCLA Medical Center

    Torrance, California · Not yet recruiting

  • Yale New Haven Hospital

    New Haven, Connecticut · Recruiting

  • Christiana Hospital

    Newark, Delaware · Recruiting

  • Nemours Children's Hospital

    Wilmington, Delaware · Recruiting

  • Children's National Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Orlando Regional Medical Center

    Orlando, Florida · Recruiting

  • Grady Memorial Hospital

    Atlanta, Georgia · Active not recruiting

  • Arthur M. Blank Hospital

    Atlanta, Georgia · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Not yet recruiting

  • Rush University Medical Center

    Chicago, Illinois · Recruiting

  • University of Illinois Hospital

    Chicago, Illinois · Not yet recruiting

  • Comer Children's Hospital

    Chicago, Illinois · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • IU Health Methodist Hospital

    Indianapolis, Indiana · Recruiting

  • Riley Hospital for Children

    Indianapolis, Indiana · Recruiting

  • University of Iowa Medical Center

    Iowa City, Iowa · Recruiting

  • University Medical Center New Orleans

    New Orleans, Louisiana · Not yet recruiting

  • University of Maryland Medical Center

    Baltimore, Maryland · Recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • University of Michigan University Hospital

    Ann Arbor, Michigan · Recruiting

  • Detroit Receiving Hospital

    Detroit, Michigan · Recruiting

  • Sinai-Grace Hospital

    Detroit, Michigan · Recruiting

  • Henry Ford Hospital

    Detroit, Michigan · Not yet recruiting

  • University of Minnesota Masonic Children's Hospital

    Minneapolis, Minnesota · Recruiting

  • Hennepin County Medical Center

    Minneapolis, Minnesota · Not yet recruiting

  • University of Minnesota Medical Center

    Minneapolis, Minnesota · Recruiting

  • Cooper University Hospital

    Camden, New Jersey · Not yet recruiting

  • University of New Mexico Hospital

    Albuquerque, New Mexico · Not yet recruiting

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.